In Australia eight products were approved via this initiative between July 2018 and May 2020: five oncology products (apalutamide, abemaciclib, niraparib, darolutamide and isatuximab), two for a cardiology indication (tafamidis and tafamidis meglumine) and baloxavir marboxil indicated for the treatment of influenza
Cardiovascular system: Protects the cardiovascular system and contributes to maintaining cholesterol levels the optimal parameters for health
Why acupuncture point injection therapy
The existence of an affiliate relationship does not influence the factual accuracy, completeness, or editorial integrity of the content presented
Sci Rep 6:31899 Chin Y-T, Wang L-M, Hsieh M-T, Shih Y-J, Nana AW, Changou CA, Yang Y-CS, Chiu H-C, Fu E et al (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells